18:30
- 21:30 |
|
|
|
| |
|
|
| |
|
07:30
|
Registration & Exhibition
opens |
07:30-09:00 |
Continental
Breakfast |
09:00-10:30 |
Interactive
Parallel Workshops |
|
|
10:45-11:30 |
Welcome
& Opening Remarks |
| |
• Carola
Schropp, Managing Partner, EBD Group |
| • Filippo
Penati, President, Province of Milan |
| • Ambassador
Umberto Vattani, President, Italian Institute for
Foreign Trade (ICE) |
• |
Dr.
Roberto Gradnik, President of Assobiotec; Senior
Executive VP, Merck Serono International, Commercial Europe |
• Dr.
Sergio Dompé, President, Farmindustria |
| • James
C. Greenwood, President & CEO, Biotechnology
Industry Organization (BIO) |
| • Dr.
Rolf Hoffmann, Senior VP ,
Amgen International |
|
11:30-12:30 |
Opening
Plenary Session |
| • |
Rethinking
the Biotech-Pharma Partnering Model
|
12:30-13:30 |
Luncheon |
13:30-18:15 |
Afternoon
Panels |
13:30-18:15 |
BUSINESS
DEVELOPMENT TRACK |
| |
| • Biotech to Biotech
Deals - How does Big Pharma look at these Collaborations? |
• The
Globalization of Dealmaking – What Is The Most Effective
Strategy for Accessing Non-Traditional Markets and Resources? |
• Size isn’t
Everything – Can Mid-Size Pharma Compete For The
Best In-Licensing Opportunities? |
| • Bio-Drug Discovery –
The Combination of White & Red Biotechnologies |
|
13:30-18:15 |
THERAPEUTIC
SESSIONS |
| |
• Oncology |
• What is Next in
the Antibody Space? |
• Infectious Diseases |
| • Central Nervous System
(CNS) |
|
13:30-18:00 |
IN
THE SPOTLIGHT |
| |
• |
Country Seminar
InvestInItaly
Italy: A Platform for
Successful Growth and Innovative Business |
• |
Biotechnology in Italy 2007:
A Financial and Strategic Analysis
BLOSSOM ASSOCIATI - ASSOBIOTEC REPORT |
• How
to Tackle the financial Gap in Italy - Critical Factors
and Experiences |
| • Spotlight
on Europe |
|
|
|
|
19:00 |
Host
Sponsor Reception & Dinner |
|
| |
| sponsored
by: |
| |
| Location: |
Hotel
Principe di Savoia *****
Piazza della Repubblica, 17
20124 Milan
www.hotelprincipedisavoia.com
|
Shuttle
Bus: |
Departure Conference
Center
18:30-19:00
Departure from Evening
Event to all Conference Hotels
21:30-22:30
(every 20 minutes) |
|
|
|
07:30 |
Registration & Exhibition opens |
07:30-09:00 |
Continental
Breakfast |
| |
|
| |
|
08:00-09:00
Blue Hall 2 |
Breakfast
Briefing & Roundtable Discussion:
|
|
The recent US elections caused a major
shift from Republican to Democratic control in the U.S.
Congress. A key impact of this changed environment will
likely be increased scrutiny of the biotech industry and
its practices, which may lead to more regulation and greater
pressures for price controls. If so, what impact will this
have on the global biotechnology industry? What will it
mean for the drug approval process?
James Greenwood, President & CEO
and Alan Eisenberg, Executive Vice President, Emerging
Companies Section, Biotechnology Industry Organization,
will brief participants on BIO's view of this new environment
and challenges, and enter into a broader discussion with
our European colleagues. |
|
| |
|
08:00-13:00 |
Partnering
one-to-one Meetings |
09:00-13:00 |
Company
Presentations |
13:00-14:00 |
Luncheon |
|
|
|
|
14:00-17:30 |
Company
Presentations |
14:00-18:30 |
Partnering
one-to-one Meetings |
19:00 |
Host
Sponsor Reception & Dinner |
|
|
|
|
07:30 |
Registration & Exhibition
opens |
07:30-09:00 |
Continental
Breakfast |
08:00-13:00 |
Partnering
one-to-one Meetings |
09:30-13:00 |
Company
Presentations |
13:00-14:00 |
Luncheon |
14:00-17:00 |
Partnering
one-to-one Meetings |
16:30 |
Closing
Reception |
